Can Fite (Israel) Market Value
| CANF Stock | 1.00 0.00 0.00% |
| Symbol | Can |
Can Fite 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Can Fite's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Can Fite.
| 01/09/2024 |
| 12/29/2025 |
If you would invest 0.00 in Can Fite on January 9, 2024 and sell it all today you would earn a total of 0.00 from holding Can Fite Biopharma or generate 0.0% return on investment in Can Fite over 720 days. Can Fite is related to or competes with BioLine RX, Clal Biotechnology, Evogene, XTL Biopharmaceutica, BioLight Life, Together Startup, and Purple Biotech. Can-Fite BioPharma Ltd., a clinical-stage biopharmaceutical company, develops small molecule therapeutic products for th... More
Can Fite Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Can Fite's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Can Fite Biopharma upside and downside potential and time the market with a certain degree of confidence.
Can Fite Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Can Fite's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Can Fite's standard deviation. In reality, there are many statistical measures that can use Can Fite historical prices to predict the future Can Fite's volatility.Can Fite Biopharma Backtested Returns
We have found three technical indicators for Can Fite Biopharma, which you can use to evaluate the volatility of the firm. The firm shows a Beta (market volatility) of 0.0, which signifies not very significant fluctuations relative to the market. the returns on MARKET and Can Fite are completely uncorrelated.
Auto-correlation | -0.09 |
Very weak reverse predictability
Can Fite Biopharma has very weak reverse predictability. Overlapping area represents the amount of predictability between Can Fite time series from 9th of January 2024 to 3rd of January 2025 and 3rd of January 2025 to 29th of December 2025. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Can Fite Biopharma price movement. The serial correlation of -0.09 indicates that less than 9.0% of current Can Fite price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.09 | |
| Spearman Rank Test | -0.36 | |
| Residual Average | 0.0 | |
| Price Variance | 0.16 |
Can Fite Biopharma lagged returns against current returns
Autocorrelation, which is Can Fite stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Can Fite's stock expected returns. We can calculate the autocorrelation of Can Fite returns to help us make a trade decision. For example, suppose you find that Can Fite has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Can Fite regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Can Fite stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Can Fite stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Can Fite stock over time.
Current vs Lagged Prices |
| Timeline |
Can Fite Lagged Returns
When evaluating Can Fite's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Can Fite stock have on its future price. Can Fite autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Can Fite autocorrelation shows the relationship between Can Fite stock current value and its past values and can show if there is a momentum factor associated with investing in Can Fite Biopharma.
Regressed Prices |
| Timeline |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Information and Resources on Investing in Can Stock
When determining whether Can Fite Biopharma is a strong investment it is important to analyze Can Fite's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Can Fite's future performance. For an informed investment choice regarding Can Stock, refer to the following important reports:Check out Can Fite Correlation, Can Fite Volatility and Can Fite Alpha and Beta module to complement your research on Can Fite. You can also try the Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.
Can Fite technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.